Gyre Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of GYRE for the last quarter is 25.23 M USD, and it's 7.17% lower compared to the previous quarter. The net income of Q2 24 is 3.53 M USD.